As of November 6, 2026, 2 holders' latest Schedule 13D or 13G filings report owning 5% or more of Performant Healthcare, Inc. The largest reported stake is Mathew P. Arens', at 16.36%. 7 filings are on record since July 29, 2025 (Schedule 13G/A, August 14, 2025).
Sell to companies like Performant Healthcare, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: Topline Capital Management, LLC · Percent: 0% · SCHEDULE 13G/A
- · Holder: Glazer Capital, LLC · Percent: 8.4% · SCHEDULE 13G/A
- · Holder: The Vanguard Group · Percent: 4.94% · SCHEDULE 13G/A
- · Holder: Prescott Group Capital Management, L.L.C. · Percent: 0% · SCHEDULE 13D/A
- · Holder: Glazer Capital, LLC · Percent: 5.82% · SCHEDULE 13G
Performant Healthcare, Inc. has 7 Schedule 13D or 13G filings on record since 2025-07-29. 2 holders' latest filing reports 5% or more of common stock - $0.0001 par value. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 16.36% | 12,923,915 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 | |
| Glazer Capital, LLC | 8.4% | 6,756,934 | SCHEDULE 13G/A, 2025-11-13 | 2025-09-30 |
| The Vanguard Group | 4.94% | 3,976,003 | SCHEDULE 13G/A, 2025-10-30 | 2025-09-30 |
| Prescott Group Capital Management, L.L.C. | 0% | 0 | SCHEDULE 13D/A, 2025-10-23 | 2025-10-21 |
| Topline Capital Management, LLC | 0% | 0 | SCHEDULE 13G/A, 2025-11-14 | 2025-08-05 |
Holding shares or following this stake? See who's behind Performant Healthcare, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Performant Healthcare, Inc. and the records around it.
Companies that share a holder
- PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. also filed stake reports on 4 other companies: Endava plc (Nov 2026), NATURES SUNSHINE PRODUCTS INC (Aug 2026), AMERICAS CARMART INC (Aug 2026)
- First Light Asset Management, LLC also filed stake reports on 12 other companies: NeuroPace Inc (Sep 2026), Neogenomics, Inc. (Aug 2026), PALVELLA THERAPEUTICS, INC. (Aug 2026)
- Topline Capital Management, LLC also filed stake reports on 13 other companies: AMERICAN VANGUARD CORP (Feb 2026), GREEN DOT CORP (Feb 2026), KORU Medical Systems, Inc. (Feb 2026)
Watch Performant Healthcare, Inc.
Get an email when Performant Healthcare, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Performant Healthcare, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Performant Healthcare, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Performant Healthcare, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Purpose of Transaction (Item 4)
Prescott Group Capital Management, L.L.C.
Item 4 of Schedule 13D is supplemented and superseded, as the case may be, as follows: On October 21, 2025 (the "Closing Date"), Continental Buyer, Inc., a Delaware corporation ("Parent"), completed the previously announced acquisition of Issuer, pursuant to the Agreement and Plan of Merger, dated as of July 31, 2025 (the "Merger Agreement"), by and among the Issuer, Parent and Project Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Sub"). Pursuant to the terms of the Merger Agreement, on the Closing Date, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Surviving Corporation"). At the effective time of the Merger (the "Effective Time"), each share of Common Stock issued and outstanding immediately prior to the Effective Time (other than any Common Stock held by (i) the Issuer as treasury stock or held directly by Parent or Merger Sub (or any direct or indirect wholly owned subsidiaries of the Issuer, Parent, or Merger Sub) or (ii) stockholders who have not voted in favor of, or consented in writing to, the adoption and approval of the Merger Agreement, and who are entitled to and have properly demanded appraisal of such Common Stock in accordance with Section 262 of the DGCL) was cancelled and converted into the right to receive an amount in cash, without interest, equal to $7.75. The description contained in this Item 4 of the Merger and the …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-10-23; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-29 | The Vanguard Group | 5% | SCHEDULE 13G |
| 2025-08-14 | Mathew P. Arens | 16.36% | SCHEDULE 13G/A |
| 2025-08-21 | Glazer Capital, LLC | 5.82% | SCHEDULE 13G |
| 2025-10-23 | Prescott Group Capital Management, L.L.C. | 0% | SCHEDULE 13D/A |
| 2025-10-30 | The Vanguard Group | 4.94% | SCHEDULE 13G/A |
| 2025-11-13 | Glazer Capital, LLC | 8.4% | SCHEDULE 13G/A |
| 2025-11-14 | Topline Capital Management, LLC | 0% | SCHEDULE 13G/A |
Questions about who owns Performant Healthcare, Inc.
Who owns Performant Healthcare, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Performant Healthcare, Inc.: Mathew P. Arens (16.36%, Schedule 13G/A, filed 2025-08-14) and Glazer Capital, LLC (8.4%, Schedule 13G/A, filed 2025-11-13).
Who are the largest shareholders of Performant Healthcare, Inc.?
By the share each holder's latest filing reports, the largest holders of Performant Healthcare, Inc. on this page are Mathew P. Arens (16.36%) and Glazer Capital, LLC (8.4%).
When did Mathew P. Arens buy into Performant Healthcare, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Mathew P. Arens on this page is the Schedule 13G/A, filed 2025-08-14, reporting 16.36%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 7 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Performant Healthcare, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.